Standard Operating Procedure for Weekly Regulatory Alert Review and Escalation

Department	Regulatory Affairs
SOP No.	RA/2026/628
Supersedes	NA
Page No.	1 of X
Issue Date	08/04/2026
Effective Date	08/04/2026
Review Date	08/04/2028

Purpose

This Standard Operating Procedure (SOP) establishes a consistent and controlled process for the weekly review and escalation of regulatory alerts relevant to the organization’s products, processes, and compliance obligations. The purpose is to ensure timely identification, assessment, and communication of regulatory changes or safety information that could impact operations, compliance status, or product lifecycle management. This SOP supports the control objective of maintaining regulatory intelligence vigilance to enable proactive and compliant regulatory actions in a regulated pharmaceutical environment.

Scope

This SOP applies to all regulatory intelligence activities related to the review of weekly regulatory alerts issued by global regulatory authorities, industry associations, and other official sources. It covers the monitoring, assessment, documentation, and escalation processes for alerts impacting any dosage form, functional area, process, validation, calibration, equipment operation, cleaning, sampling, warehousing, documentation, engineering, laboratory, quality assurance, quality control, manufacturing, utilities, or compliance activities. Activities outside regulatory alert review and escalation, such as routine reporting or unrelated compliance audits, are excluded.

Responsibilities

• Regulatory Intelligence Analyst: Collect, review, and summarize regulatory alerts weekly.
• Regulatory Affairs Manager: Review summarized alerts, determine impact, and coordinate escalation if required.
• Quality Assurance Representative: Participate in review meetings and validate compliance impacts.
• Department Heads: Receive escalated alerts, assess operational impact, and initiate corrective/preventive actions.
• Document Control Coordinator: Ensure proper filing, version control, and record retention of the alert review documentation.

Accountability

The Regulatory Affairs Head is accountable for overall implementation, compliance with this SOP, reviewing effectiveness periodically, and ensuring escalation paths are properly followed. This role is responsible for ensuring that the SOP is updated as necessary to reflect regulatory changes and internal process improvements.

Procedure

1. Preparation and Prerequisites: Regulatory Intelligence Analyst subscribes to relevant regulatory agency mailing lists, databases, and industry newsletters to receive alerts promptly. Ensure access to internal quality management and document control systems for recording and archiving.

2. Safety and GMP Checks: Confirm that all received regulatory alerts are authenticated from official sources and pertain to the company’s market and product portfolio.

3. Execution of Weekly Review: Conduct weekly triage every Friday afternoon or defined schedule, reviewing all received alerts for the week. Categorize alerts by regulatory authority, product impact, and risk level.

4. Impact Assessment: Regulatory Intelligence Analyst prepares a summary report listing each alert with a brief description and initial impact judgement. The Regulatory Affairs Manager reviews this summary with Quality Assurance and relevant stakeholders to validate and finalize impact assessments.

5. Escalation Process: Alerts assessed as critical or affecting compliance, safety, labeling, or market authorization shall be escalated within 24 hours post-review meeting to appropriate Department Heads for action. Document all escalation communications and acknowledge receipt.

6. Documentation and Record Retention: Maintain a Regulatory Alert Register recording all reviewed alerts, decisions made, assessments, and escalation details. Upload the weekly summary report and register to the document control system within the same business day.

7. Periodic Review and Training: Conduct quarterly reviews of the alert management process for completeness and timeliness. Provide training updates to involved personnel if procedural changes or new regulatory sources are identified.

8. Handling Deviations: Any missed alerts, delays, or procedural exceptions must be documented as deviations, investigated, and corrective/preventive actions implemented.

9. Closure: Confirm closure of all actions arising from escalated alerts with documented evidence. The Regulatory Affairs Manager reviews closure status monthly and reports to Quality Governance committees as applicable.

Abbreviations

• GMP – Good Manufacturing Practice
• QA – Quality Assurance
• RA – Regulatory Affairs
• QC – Quality Control
• SOP – Standard Operating Procedure
• CAPA – Corrective and Preventive Actions

Documents

The following documents are required to ensure compliance with this SOP topic:

1. Weekly Regulatory Alert Summary Report (Annexure-1)
2. Regulatory Alert Register and Escalation Log (Annexure-2)
3. Escalation Notification Template (Annexure-3)

References

• ICH Q10 Pharmaceutical Quality System Guidelines
• FDA Guidance on Regulatory Submissions and Correspondence
• EU GMP Annex 15 – Qualification and Validation
• ICH Q9 Quality Risk Management
• Company Quality Management System Documentation Requirements

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Weekly Regulatory Alert Summary Report

Purpose: To summarize and categorize weekly regulatory alerts for assessment and further action.

Alert No.	Date Received	Source Authority	Alert Title	Product/Area Impacted	Risk Level	Initial Assessment Summary
001	01/04/2026	FDA	New Labeling Requirement Update	Oral Solid Dosage Forms	Medium	Requires product label revision within 3 months
002	03/04/2026	EMA	Updated Stability Testing Guidelines	Injectable Products	Low	Inform QA/QC for method update consideration
003	05/04/2026	WHO	Safety Alert on API Contamination	API Manufacturing	High	Immediate risk mitigation and batch hold recommended

Annexure-2: Regulatory Alert Register and Escalation Log

Purpose: To maintain a comprehensive log of regulatory alerts reviewed, decisions made, and escalation activities.

Alert No.	Date Reviewed	Outcome	Escalated To	Escalation Date	Follow-up Actions	Status
001	06/04/2026	Labeling update required	Regulatory Affairs Manager	06/04/2026	Initiate artwork change	In Progress
003	06/04/2026	Critical safety risk identified	Manufacturing Head	06/04/2026	Batch hold and investigation	Completed

Annexure-3: Escalation Notification Template

Purpose: To formally notify responsible departments about critical regulatory alerts requiring immediate attention.

Date:	06/04/2026
To:	Department Head
From:	Regulatory Affairs Manager
Subject:	Escalation of Regulatory Alert No. 003 – API Contamination Safety Advisory
Details:	A critical safety alert issued by WHO regarding potential contamination in the API manufacturing process has been identified. Immediate action is required to hold affected batches and initiate root cause investigation.
Requested Actions:	Hold all potentially impacted API batches. Investigate and report findings within 48 hours. Implement containment and CAPA measures as appropriate.
Confirmation of Receipt:	Signature and Date

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
08/04/2026	1.0	Initial issue	New SOP creation